Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Automation
Return to: PBR Home | Automation
Today in Automation

Automation

MIMETAS, Galapagos to develop human disease models on-a-chip technology MIMETAS and Galapagos have entered into a research collaboration to develop organ-on-a-chip-based human disease models for new medicine development. Automation > IT & Software > News

Latest Automation News by Sector

Select a sector from the list or browse by sector below:

IT & Software

NeoStem enters into license deal with Rockefeller University to expand cancer immunotherapy
NeoStem (NBS), a leader in the emerging cellular therapy industry, announced that the Company has entered into an exclusive license agreement with The Rockefeller University for patented technologies that further expand the Company's intellectual property portfolio associated with its Targeted Cancer Immunotherapy Program.
Automation > IT & Software > News
Prosonix confirms potential of MCP Technology to develop new FDC therapies for respiratory diseases
Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces that it has confirmed the potential of its Multi-component Particle (MCP) Technology for creating novel inhaled, dual and triple fixed dose combination (FDC) therapies for respiratory diseases.
Automation > IT & Software > News

Laboratory Instrumentation

Cepheid, pharma firms collaborate on diagnostic test for multidrug-resistant bacterial infections
By PBR Staff Writer
Cepheid has entered into a new collaboration with AstraZeneca, Cubist and GSK to encourage transformational change in infectious disease therapy.
Automation > Laboratory Instrumentation > News
BioLight announces start of clinical study with DiagnosTear dry eye syndrome diagnostic assay
BioLight Life Sciences Investments announced that DiagnosTear has received all necessary approvals from Sheba Medical Center near Tel Aviv to begin a clinical study with its TeaRx, point-of-care Dry Eye Syndrome diagnostic assay. DiagnosTear is part of BioLight’s XLVision Sciences ophthalmology cluster.
Automation > Laboratory Instrumentation > News